Uncategorized
Analyst Expectations For Neurocrine Biosciences’s Future
Latest Ratings for NBIX Date Firm Action From To Mar 2022 Piper Sandler Downgrades Overweight Neutral Feb 2022 Goldman Sachs Upgrades Neutral Buy Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for NBIX View the Latest Analyst Ratings read more
Forecasting The Future: 4 Analyst Projections For Omega Healthcare Invts
Latest Ratings for OHI Date Firm Action From To Feb 2022 Credit Suisse Maintains Neutral Feb 2022 Raymond James Maintains Outperform Feb 2022 Credit Suisse Initiates Coverage On Neutral View More Analyst Ratings for OHI View the Latest Analyst Ratings read more
Beyond The Numbers: 47 Analysts Discuss Amazon.com Stock
Latest Ratings for AMZN Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Buy Feb 2022 Tigress Financial Maintains Buy Feb 2022 Credit Suisse Maintains Outperform View More Analyst Ratings for AMZN View the Latest Analyst Ratings read more
The Fed Will Not Save Us This Year
There are no emergency Fed interest rate cuts coming, because the economy is way too strong, says financial influencer Gav Blaxberg. read more
What’s Going On With Meta Shares Today?
Meta Platforms Inc. (NASDAQ: META) shares are trading higher Monday following reports that the company is preparing to launch a fully automated ad creation system powered by artificial intelligence by the end of 2026. read more
Forecasting The Future: 11 Analyst Projections For Samsara
Latest Ratings for IOT Date Firm Action From To Mar 2022 Morgan Stanley Maintains Overweight Mar 2022 Wells Fargo Maintains Overweight Jan 2022 Cowen & Co. Initiates Coverage On Outperform View More Analyst Ratings for IOT View the Latest Analyst Ratings read more